February 24, 2024

The Intravenous (IV) Hydration Therapy Market in Europe is driven by increasing adoption of hydration therapy services

The European IV hydration therapy market has seen significant growth in recent years owing to rising consumer awareness about the benefits of hydration therapy. IV hydration therapy involves administering medication, fluids, vitamins or minerals directly into a vein through an intravenous catheter. It is commonly used to treat dehydration, electrolyte imbalances, migraines or hangovers. The therapy utilizes 100% pharmaceutical grade ingredients to provide hydration to cells faster than oral or topical hydration methods. It allows rapid administration of fluids and nutrients directly into the bloodstream, bypassing the gastrointestinal tract. The therapy not only helps restore hydration and proper functioning of the body but also provides several health advantages like boosting energy levels, improving skin elasticity and diminishing fine lines and wrinkles. IV therapy is an effective option for patients dealing with severe nausea, vomiting or inability to keep fluids down orally. The increasing prevalence of lifestyle diseases and busy schedules leaving little time for self-care have propelled the demand for quick-fix hydration therapy services across Europe.

The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising adoption of aesthetic IV therapy services is one of the key trends being witnessed in the European IV hydration therapy market. In addition to hydration, IV therapy can also deliver essential nutrients, vitamins and antioxidants that help reduce signs of aging. It helps improve skin quality, boost collagen production and diminish fine lines and wrinkles. The surge in non-medical IV therapy centers offering aesthetic hydration packages to address issues like dull skin, dark circles and bloating is fueling the market growth. The availability of multi-vitamin IV drips, ‘sexy legs’ packages and vitamin B12 shots for improved skin is garnering enormous popularity among younger consumers in Europe. Furthermore, growing preference for non-surgical, minimally invasive aesthetic treatments over cosmetic procedures is augmenting the demand for IV therapy in aesthetics applications across the region.

Porter’s Analysis
Threat of new entrants: Low. Considerable capital is required to enter the IV therapy market due to strict regulations and standards. The market also has dominant players making it difficult for new players.
Bargaining power of buyers: Moderate. Customers have bargaining power due to availability of alternatives, but the need for IV therapy limits their power.
Bargaining power of suppliers: Moderate. Suppliers have moderate power due to differentiated products and services in an oligopolistic market. However, large customers can negotiate better.
Threat of new substitutes: Low. No substitutes exist as IV therapy is unique in delivering nutrients directly into the bloodstream. Oral medications provide a weak substitute.
Competitive rivalry: High. The market has many players offering similar products resulting in intense competition on technology, quality, services and price.

Key Takeaways
The Europe IV Hydration Therapy Market Size is expected to witness high growth over the forecast period. The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.

Germany dominates the region holding over 25% of the share in 2022 due to favorable reimbursement policies and supportive government initiatives. Italy and France also have a sizeable market supported by robust healthcare infrastructure. North America holds a significant share in the global market due infrastructure modernization projects spearheaded by the governments in the region. However, Europe is expected to register the highest growth during the forecast period led by Germany, Italy and the UK. The growth can be attributed to rising elderly populationbase, increasing adoption of advanced therapies and growing awareness.

Key players: Key players operating in the European IV hydration therapy market are Thermo Fisher Scientific Inc, B. Braun Melsungen AG, Baxter, Fresenius Kabi AG, Vifor Pharma Management Ltd. These players are focusing on new product launches and adopting inorganic growth strategies like collaborations and partnerships to gain market share.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it